[1]JournaloftheAmericanChemicalSociety,1981,vol.103,p.4142-4145
Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
29681-21-8
31290-76-3
53609-62-4
102867-56-1
52788-79-1
77078-22-9
289042-11-1 | Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(n-methyl-n-methylsulfonyl)amino]pyrimidine-5-carboxylate | AA002WXZ | MFCD08235142
291-21-4 | 1,3,5-Trithiane | AA002X8K | MFCD00006653
29211-68-5 | 5-tert-Butyl-2,4-dihydro-3h-pyrazol-3-one | AA002XMN | MFCD00051760
29312-99-0 | 2,5-Dibromonicotinic acid | AA002XYZ | MFCD06254512
29426-64-0 | Dl-alpha-amino-epsilon-caprolactam HCl | AA002YAB | MFCD06798179
29540-54-3 | Methyl 2-methyl-3-oxo-3-phenylpropanoate | AA002YMG | MFCD00956709
2967-54-6 | 3,5-Difluoro-4-hydroxybenzonitrile | AA002YYX | MFCD09033181
302333-80-8 | 4-Cyclopropylphenylboronic acid | AA002Z99 | MFCD01309064
303085-53-2 | 6-Chloropyridazine-3-carbaldehyde | AA002ZIL | MFCD10698041
30377-07-2 | N-Decanoylsarcosine sodium salt | AA002ZUP | MFCD00451533